Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy

Regenerative Medicine

Volumn 6, Issue 3, 2011, Pages 335-349

  Kim, Sung Whan ^a   Kim, Hyongbum ^b   Yoon, Young Sup ^c  

^a Dong A University   (South Korea)

^b Hanyang University   (South Korea)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; cardiovascular disease; CD31; ischemia; progenitors; stem cells; vasculogenesis

Indexed keywords

CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; NEUROPILIN 1; VASCULOTROPIN RECEPTOR 2;

ADULT STEM CELL; ANGIOGENESIS; ANTIGEN EXPRESSION; CARDIOVASCULAR CELL THERAPY; CELL ADHESION; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL ISOLATION; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELL REGENERATION; CELL RENEWAL; CELL SELECTION; CELL SPECIFICITY; CELL SURFACE; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; CELL TYPE; COLONY FORMING CELL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENDOTHELIAL PROGENITOR CELL; ENRICHMENT CULTURE; GENE EXPRESSION PROFILING; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; STEM CELL EXPANSION; STEM CELL MOBILIZATION; TISSUE REGENERATION;

ANTIGENS, CD31; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

EID: 79955870166     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.11.24     Document Type: Review

References (135)

1. Lloyd-Jones D, Adams R, Carnethon M et al.: Heart disease and stroke statistics -2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3), 480-486 (2009).
2. Dimmeler S, Zeiher AM, Schneider MD: Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest. 115(3), 572-583 (2005). (Pubitemid 40322227)
3. Laflamme MA, Murry CE: Regenerating the heart. Nat. Biotechnol. 23(7), 845-856 (2005). (Pubitemid 43093128)
4. Wollert KC, Drexler H: Clinical applications of stem cells for the heart. Circ. Res. 96(2), 151-163 (2005). (Pubitemid 40209362)
5. Ferrari G, Cusella-De Angelis G, Coletta M et al.: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279(5356), 1528-1530 (1998). (Pubitemid 28217075)
6. Gussoni E, Soneoka Y, Strickland CD et al.: Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401(6751), 390-394 (1999). (Pubitemid 29454964)
7. Jackson KA, Majka SM, Wang H et al.: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107(11), 1395-1402 (2001). (Pubitemid 32522033)
8. Orlic D, Kajstura J, Chimenti S et al.: Bone marrow cells regenerate infarcted myocardium. Nature 410(6829), 701-705 (2001). (Pubitemid 32290358)
9. Krause DS, Theise ND, Collector MI et al.: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105(3), 369-377 (2001). (Pubitemid 32455343)
10. Brazelton TR, Rossi FM, Keshet GI et al.: From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290(5497), 1775-1779 (2000). (Pubitemid 32004810)
11. Minami E, Laflamme MA, Saffitz JE et al.: Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112(19), 2951-2958 (2005). (Pubitemid 41612297)
12. Laflamme MA, Myerson D, Saffitz JE et al.: Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ. Res. 90(6), 634-640 (2002). (Pubitemid 34640880)
13. Quaini F, Urbanek K, Beltrami AP et al.: Chimerism of the transplanted heart. N. Engl. J. Med. 346(1), 5-15 (2002). (Pubitemid 34438914)
14. van Praag H, Schinder AF, Christie BR et al.: Functional neurogenesis in the adult hippocampus. Nature 415(6875), 1030-1034 (2002). (Pubitemid 34193451)
15. Assmus B, Schachinger V, Teupe C et al.: Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106(24), 3009-3017 (2002). (Pubitemid 35440281)
16. Hare JM, Traverse JH, Henry TD et al.: A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54(24), 2277-2286 (2009).
17. Assmus B, Rolf A, Erbs S et al.: Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ. Heart Fail. 3(1), 89-96 (2010).
18. Tatsumi T, Ashihara E, Yasui T et al.: Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ. J. 71(8), 1199-1207 (2007). (Pubitemid 47201778)
19. Miettinen JA, Ylitalo K, Hedberg P et al.: Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy. Heart 96(5), 362-367 (2010).
20. Janssens S, Dubois C, Bogaert J et al.: Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367(9505), 113-121 (2006). (Pubitemid 43077127)
21. Lunde K, Solheim S, Aakhus S et al.: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355(12), 1199-1209 (2006). (Pubitemid 44427444)
22. Meyer GP, Wollert KC, Lotz J et al.: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113(10), 1287-1294 (2006). (Pubitemid 43739450)
23. Penicka M, Horak J, Kobylka P et al.: Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study. J. Am. Coll. Cardiol. 49(24), 2373-2374 (2007). (Pubitemid 46891709)
24. Gilbert SF: Developmental Biology (5th Edition) Sinauer Associates, Sunderland, MA, USA (1997).
25. Risau W, Flamme I: Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73-91 (1995). (Pubitemid 26019602)
26. Asahara T, Murohara T, Sullivan A et al.: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302), 964-967 (1997). (Pubitemid 27087709)
27. Asahara T, Masuda H, Takahashi T et al.: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85(3), 221-228 (1999). (Pubitemid 29377293)
28. Kalka C, Masuda H, Takahashi T et al.: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl Acad. Sci. USA 97(7), 3422-3427 (2000). (Pubitemid 30183318)
29. Shi Q, Rafii S, Wu MH et al.: Evidence for circulating bone marrow-derived endothelial cells. Blood 92(2), 362-367 (1998). (Pubitemid 28323695)
30. Peichev M, Naiyer AJ, Pereira D et al.: Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95(3), 952-958 (2000). (Pubitemid 30062717)
31. Fernandez Pujol B, Lucibello FC, Gehling UM et al.: Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65(5), 287-300 (2000). (Pubitemid 30406634)
32. Dimmeler S, Zeiher AM: Endothelial cell apoptosis in angiogenesis and vessel regression. Circ. Res. 87(6), 434-439 (2000).
33. Dimmeler S, Aicher A, Vasa M et al.: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108(3), 391-397 (2001). (Pubitemid 32730785)
34. Schmeisser A, Garlichs CD, Zhang H et al.: Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc. Res. 49(3), 671-680 (2001). (Pubitemid 32146430)
35. Rehman J, Li J, Orschell CM et al.: Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107(8), 1164-1169 (2003). (Pubitemid 36297209)
36. Ingram DA, Caplice NM, Yoder MC: Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 106(5), 1525-1531 (2005). (Pubitemid 41208561)
37. Gulati R, Jevremovic D, Peterson TE et al.: Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93(11), 1023-1025 (2003). (Pubitemid 37485031)
38. Hill JM, Zalos G, Halcox JP et al.: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348(7), 593-600 (2003). (Pubitemid 36204953)
39. Lin Y, Weisdorf DJ, Solovey A et al.: Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105(1), 71-77 (2000). (Pubitemid 30036389)
40. Ingram DA, Mead LE, Tanaka H et al.: Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104(9), 2752-2760 (2004). (Pubitemid 39434958)
41. Yoon CH, Hur J, Park KW et al.: Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112(11), 1618-1627 (2005). (Pubitemid 41324524)
42. Reya T, Morrison SJ, Clarke MF et al.: Stem cells, cancer, and cancer stem cells. Nature 414(6859), 105-111 (2001). (Pubitemid 33041634)
43. Weissman IL: Stem cells: units of development, units of regeneration, and units in evolution. Cell 100(1), 157-168 (2000). (Pubitemid 30046304)
44. Goodell MA, Brose K, Paradis G et al.: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183(4), 1797-1806 (1996). (Pubitemid 26134320)
45. Murry CE, Soonpaa MH, Reinecke H et al.: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428(6983), 664-668 (2004). (Pubitemid 38524810)
46. Balsam LB, Wagers AJ, Christensen JL et al.: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428(6983), 668-673 (2004). (Pubitemid 38524811)
47. Wang J, Zhang S, Rabinovich B et al.: Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ. Res. 106(12), 1904-1911 (2010).
48. +-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108(17), 2070-2073 (2003). (Pubitemid 37337581)
49. Losordo DW, Schatz RA, White CJ et al.: Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a Phase I/IIa double-blind, randomized controlled trial. Circulation 115(25), 3165-3172 (2007). (Pubitemid 47018140)
50. Kawamoto A, Iwasaki H, Kusano K et al.: CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 114(20), 2163-2169 (2006). (Pubitemid 44747897)
51. Flores-Ramirez R, Uribe-Longoria A, Rangel-Fuentes MM et al.: Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency. Cardiovasc. Revasc. Med. 11(2), 72-78 (2010).
52. Schots R, De Keulenaer G, Schoors D et al.: Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure. Exp. Hematol. 35(12), 1884-1890 (2007). (Pubitemid 350123662)
53. Leor J, Guetta E, Feinberg MS et al.: Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells 24(3), 772-780 (2006). (Pubitemid 44464782)
54. Pittenger MF, Mackay AM, Beck SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science 284(5411), 143-147 (1999). (Pubitemid 29282067)
55. Madonna R, Geng YJ, De Caterina R: Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arterioscler. Thromb. Vasc. Biol. 29(11), 1723-1729 (2009).
56. Antonucci I, Stuppia L, Kaneko Y et al.: Amniotic fluid as rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant. (2010) (Epub ahead of print).
57. Troyer DL, Weiss ML: Whartons jelly-derived cells are a primitive stromal cell population. Stem Cells 26(3), 591-599 (2008).
58. Ciavarella S, Dammacco F, De Matteo M et al.: Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts. Stem Cells Dev. 18(8), 1211-1220 (2009).
59. Makino S, Fukuda K, Miyoshi S et al.: Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103(5), 697-705 (1999). (Pubitemid 29122423)
60. Amado LC, Saliaris AP, Schuleri KH et al.: Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl Acad. Sci. USA 102(32), 11474-11479 (2005). (Pubitemid 41153844)
61. Jaquet K, Krause KT, Denschel J et al.: Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? Stem Cells Dev. 14(3), 299-309 (2005). (Pubitemid 40885254)
62. Mangi AA, Noiseux N, Kong D et al.: Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9(9), 1195-1201 (2003). (Pubitemid 37173705)
63. Gnecchi M, He H, Liang OD et al.: Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11(4), 367-368 (2005). (Pubitemid 40562318)
64. Kinnaird T, Stabile E, Burnett MS et al.: Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94(5), 678-685 (2004). (Pubitemid 38387752)
65. Kinnaird T, Stabile E, Burnett MS et al.: Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109(12), 1543-1549 (2004). (Pubitemid 38420184)
66. Melo LG, Agrawal R, Zhang L et al.: Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105(5), 602-607 (2002). (Pubitemid 34123435)
67. Wang X, McCullough KD, Franke TF et al.: Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275(19), 14624-14631 (2000). (Pubitemid 30339753)
68. Tang YL, Tang Y, Zhang YC et al.: Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol. 46(7), 1339-1350 (2005). (Pubitemid 41615559)
69. Boyle AJ, McNiece IK, Hare JM: Mesenchymal stem cell therapy for cardiac repair. Methods Mol. Biol. 660, 65-84 (2010).
70. Di Nicola M, Carlo-Stella C, Magni M et al.: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10), 3838-3843 (2002). (Pubitemid 34534559)
71. Krampera M, Glennie S, Dyson J et al.: Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101(9), 3722-3729 (2003). (Pubitemid 36857965)
72. Majumdar MK, Keane-Moore M, Buyaner D et al.: Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 10(2), 228-241 (2003). (Pubitemid 36302404)
73. Barry FP, Murphy JM, English K et al.: Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Dev. 14(3), 252-265 (2005). (Pubitemid 40885249)
74. Tolar J, Nauta AJ, Osborn MJ et al.: Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25(2), 371-379 (2007). (Pubitemid 46232791)
75. Miura M, Miura Y, Padilla-Nash HM et al.: Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24(4), 1095-1103 (2006). (Pubitemid 44464742)
76. Zhou YF, Bosch-Marce M, Okuyama H et al.: Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res. 66(22), 10849-10854 (2006). (Pubitemid 44876981)
77. Ziegelhoeffer T, Fernandez B, Kostin S et al.: Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 94(2), 230-238 (2004). (Pubitemid 38197456)
78. Fuchs U, Zittermann A, Suhr O et al.: Heart transplantation in a 68-year-old patient with senile systemic amyloidosis. Am. J. Transplant. 5(5), 1159-1162 (2005). (Pubitemid 40571269)
79. Kamihata H, Matsubara H, Nishiue T et al.: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104(9), 1046-1052 (2001). (Pubitemid 32803883)
80. Barcelos LS, Duplaa C, Krankel N et al.: Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ. Res. 104(9), 1095-1102 (2009).
81. Yoon YS, Wecker A, Heyd L et al.: Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115(2), 326-338 (2005). (Pubitemid 40385474)
82. Urbich C, Aicher A, Heeschen C et al.: Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell Cardiol. 39(5), 733-742 (2005). (Pubitemid 41464410)
83. Tateno K, Minamino T, Toko H et al.: Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ. Res. 98(9), 1194-1202 (2006). (Pubitemid 43948106)
84. Terada N, Hamazaki T, Oka M et al.: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416(6880), 542-545 (2002). (Pubitemid 34288856)
85. Ying QL, Nichols J, Evans EP et al.: Changing potency by spontaneous fusion. Nature 416(6880), 545-548 (2002). (Pubitemid 34288857)
86. Nygren JM, Jovinge S, Breitbach M et al.: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10(5), 494-501 (2004). (Pubitemid 38667908)
87. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al.: Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425(6961), 968-973 (2003). (Pubitemid 37376928)
88. Albelda SM, Muller WA, Buck CA et al.: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J. Cell Biol. 114(5), 1059-1068 (1991). (Pubitemid 21909867)
89. Xie Y, Muller WA: Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc. Natl Acad. Sci. USA 90(12), 5569-5573 (1993). (Pubitemid 23176202)
90. Muller WA, Weigl SA, Deng X et al.: PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178(2), 449-460 (1993). (Pubitemid 23218193)
91. Berman ME, Xie Y, Muller WA: Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and b 2 integrin activation. J. Immunol. 156(4), 1515-1524 (1996). (Pubitemid 26065863)
92. Voermans C, Rood PM, Hordijk PL et al.: Adhesion molecules involved in transendothelial migration of human hematopoietic progenitor cells. Stem Cells 18(6), 435-443 (2000).
93. Noble KE, Wickremasinghe RG, DeCornet C et al.: Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. J. Immunol. 162(3), 1376-1383 (1999). (Pubitemid 29307008)
94. Ilan N, Mohsenin A, Cheung L et al.: PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J. 15(2), 362-372 (2001). (Pubitemid 32141428)
95. Newman PJ, Berndt MC, Gorski J et al.: PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247(4947), 1219-1222 (1990).
96. DeLisser HM, Christofidou-Solomidou M, Strieter RM et al.: Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am. J. Pathol. 151(3), 671-677 (1997). (Pubitemid 27385598)
97. Matsumura T, Wolff K, Petzelbauer P: Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J. Immunol. 158(7), 3408-3416 (1997). (Pubitemid 127484061)
98. Cao G, OBrien CD, Zhou Z et al.: Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am. J. Physiol. Cell Physiol. 282(5), C1181-C1190 (2002). (Pubitemid 34663126)
99. Uemura R, Xu M, Ahmad N et al.: Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98(11), 1414-1421 (2006). (Pubitemid 43948066)
100. Cho HJ, Lee N, Lee JY et al.: Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J. Exp. Med. 204(13), 3257-3269 (2007).
101. Kim H, Cho HJ, Kim SW et al.: CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ. Res. 107(5), 602-614 (2010).
102. Kim SW, Kim H, Cho HJ et al.: Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J. Am. Coll. Cardiol. 56(7), 593-607 (2010).
103. Cho CH, Kammerer RA, Lee HJ et al.: COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl Acad. Sci. USA 101(15), 5547-5552 (2004). (Pubitemid 38481194)
104. Jones N, Iljin K, Dumont DJ et al.: Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell Biol. 2(4), 257-267 (2001). (Pubitemid 33676968)
105. Mammoto A, Connor KM, Mammoto T et al.: A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457(7233), 1103-1108 (2009).
106. Iivanainen E, Nelimarkka L, Elenius V et al.: Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor. FASEB J. 17(12), 1609-1621 (2003). (Pubitemid 37100062)
107. Koch AE, Polverini PJ, Kunkel SL et al.: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258(5089), 1798-1801 (1992). (Pubitemid 23087348)
108. Lee P, Goishi K, Davidson AJ et al.: Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc. Natl Acad. Sci. USA 99(16), 10470-10475 (2002).
109. Lyden D, Hattori K, Dias S et al.: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7(11), 1194-1201 (2001). (Pubitemid 33063774)
110. ONeill TJ 4th, Wamhoff BR, Owens GK et al.: Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ. Res. 97(10), 1027-1035 (2005). (Pubitemid 41668916)
111. Smits AM, van Laake LW, den Ouden K et al.: Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc. Res. 83(3), 527-535 (2009).
112. Tang XL, Rokosh DG, Guo Y et al.: Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction. Circ. J. 74(3), 390-404 (2010).
113. Smith RR, Barile L, Cho HC et al.: Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115(7), 896-908 (2007). (Pubitemid 46294730)
114. Nolan DJ, Ciarrocchi A, Mellick AS et al.: Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 21(12), 1546-1558 (2007). (Pubitemid 46955726)
115. Gao D, Nolan DJ, Mellick AS et al.: Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319(5860), 195-198 (2008).
116. Muller-Ehmsen J, Whittaker P, Kloner RA et al.: Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell Cardiol. 34(2), 107-116 (2002). (Pubitemid 35229976)
117. Musialek P, Tekieli L, Kostkiewicz M et al.: Randomized transcoronary delivery of CD34+ cells with perfusion versus stop-flow method in patients with recent myocardial infarction: early cardiac retention of (99m)Tc-labeled cells activity. J. Nucl. Cardiol. 18(1), 104-116 (2010).
118. Jeong JO, Kim MO, Kim H et al.: Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 119(5), 699-708 (2009).
119. Zocchi MR, Poggi A: Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas. J. Natl Cancer Inst. 85(3), 246-247 (1993). (Pubitemid 23046902)
120. Woodfin A, Voisin MB, Nourshargh S: PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler. Thromb. Vasc. Biol. 27(12), 2514-2523 (2007). (Pubitemid 350158900)
121. Kawamoto A, Tkebuchava T, Yamaguchi J et al.: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107(3), 461-468 (2003). (Pubitemid 36158050)
122. Kawamoto A, Katayama M, Handa N et al.: Intramuscular transplantation of G-CSF-mobilized CD34+ cells in patients with critical limb ischemia: a Phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 27(11), 2857-2864 (2009).
123. Rafei M, Hsieh J, Zehntner S et al.: A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat. Med. 15(9), 1038-1045 (2009).
124. Stagg J, Galipeau J: Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handb. Exp. Pharmacol. (180), 45-66 (2007).
125. Kang HJ, Kim HS, Zhang SY et al.: Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363(9411), 751-756 (2004).
126. Horwitz EM, Gordon PL, Koo WK et al.: Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl Acad. Sci. USA 99(13), 8932-8937 (2002). (Pubitemid 34693661)
127. Yoon YS, Park JS, Tkebuchava T et al.: Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109(25), 3154-3157 (2004).
128. Miyamoto K, Nishigami K, Nagaya N et al.: Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 114(24), 2679-2684 (2006). (Pubitemid 44967352)
129. Iso Y, Soda T, Sato T et al.: Impact of implanted bone marrow progenitor cell composition on limb salvage after cell implantation in patients with critical limb ischemia. Atherosclerosis 209(1), 167-172 (2010).
130. Horie T, Onodera R, Akamastu M et al.: Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells. Atherosclerosis 208(2), 461-466 (2010).
131. Al Mheid I, Quyyumi AA: Cell therapy in peripheral arterial disease. Angiology 59(6), 705-716 (2008).
132. Losordo D, Kibbe M, Mendelsohn F et al.: Randomized, double-blind, placebo controlled trial of autologous CD34+ cell therapy for critical limb ischemia: 1 year results. Circulation 122, A16920 (2010).
133. Kim H, Park JS, Choi YJ et al.: Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells 27(7), 1686-1696 (2009).
134. Crisan M, Yap S, Casteilla L et al.: A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3), 301-313 (2008).
135. Campagnolo P, Cesselli D, Al Haj Zen A et al.: Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 121(15), 1735-1745 (2010).